VACCITECH (SP.ADR)/1 (2AB) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.051x

Based on the latest financial reports, VACCITECH (SP.ADR)/1 (2AB) has a cash flow conversion efficiency ratio of -0.051x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.37 Million ≈ $-3.94 Million USD) by net assets (€66.48 Million ≈ $77.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See VACCITECH (SP.ADR)/1 net asset quality index to measure how much of total assets are equity-financed.

VACCITECH (SP.ADR)/1 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how VACCITECH (SP.ADR)/1's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 2AB cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

VACCITECH (SP.ADR)/1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of VACCITECH (SP.ADR)/1 ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Woojin I&S Co Ltd KO:010400	-0.025x
Pergamon Status Dis Ticaret AS IS:PSDTC	-0.002x
Pure Hydrogen Corporation Ltd AU:PH2	-0.252x
Control Bionics Ltd AU:CBL	-0.288x
DRC Systems India Limited NSE:DRCSYSTEMS	0.019x
Next Entertainment World Co. Ltd KQ:160550	0.005x
FNC Entertainment Co Ltd KQ:173940	-0.285x
O.C.C. Public Company Limited BK:OCC	-0.033x

Annual Cash Flow Conversion Efficiency for VACCITECH (SP.ADR)/1 (2021–2025)

The table below shows the annual cash flow conversion efficiency of VACCITECH (SP.ADR)/1 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see VACCITECH (SP.ADR)/1 (2AB) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€74.29 Million ≈ $86.86 Million	€-47.98 Million ≈ $-56.09 Million	-0.646x	-190.41%
2024-12-31	€130.13 Million ≈ $152.14 Million	€-28.94 Million ≈ $-33.83 Million	-0.222x	+18.34%
2023-12-31	€187.00 Million ≈ $218.62 Million	€-50.92 Million ≈ $-59.54 Million	-0.272x	-358.95%
2022-12-31	€243.20 Million ≈ $284.33 Million	€-14.43 Million ≈ $-16.87 Million	-0.059x	+54.01%
2021-12-31	€252.56 Million ≈ $295.27 Million	€-32.58 Million ≈ $-38.09 Million	-0.129x	--

About VACCITECH (SP.ADR)/1

F:2AB Germany Biotechnology

Market Cap

$24.11 Million

€20.62 Million EUR

Market Cap Rank

#24977 Global

#2156 in Germany

Share Price

€0.51

Change (1 day)

+5.65%

52-Week Range

€0.45 - €1.54

All Time High

€14.00